Cardiovascular risks of hypertension: Lessons from observational studies

Journal of Hypertension, Supplement

Volumn 16, Issue 6, 1998, Pages

  O'Donnell, Christopher J ^a,c   Kannel, William B ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FRAMINGHAM HEART STUDY   (United States)

Author keywords

Cardiovascular risk; Diastolic blood pressure; Hypertension; Risk factor; Systolic blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR RISK; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; OBSERVATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CEREBROVASCULAR DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBSERVATION; PREVALENCE; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 0031753373     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol 1971; 27:335-346.
2. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153:598-615.
3. O'Donnell CJ, Ridker PM, Glynn RJ, Berger K, Ajani U, Manson J E, Hennekens CH. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997; 95:1132-1137.
4. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
5. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
6. Hebert PR, Moser M, Mayer J, Glynn RJ, Hennekens CH. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993; 153:578-581.
7. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lanced 1997; 350:757-764.
8. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991 ; 83:356-362.
9. Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
10. National High Blood Pressure Education Program Working Group. Report on Primary Prevention of Hypertension. Arch Intern Med 1993; 153:186-208.
11. National High Blood Pressure Education Program Working Group. Report on Hypertension in the Elderly. National High Blood Pressure Education Program Working Group. Hypertension 1994; 23:275-285.
12. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
13. Kannel WB. Bishop Lecture: contribution of the Framingham Study to preventive cardiology. J Am Coll Cardiol 1990; 15:206-211.
14. Cupples LA, D'Agostino RB, Kiely D. The Framingham Study. An epidemiological investigation of cardiovascular disease, Section 34. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements Framingham Heart Study, 30 year follow-up. Bethesda, MD: National Heart, Lung, and Blood Institute; 1987. NIA Publication No. 87-2703.
15. Byyny RL. Hypertension in the elderly. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis, and management. New York: Raven Press; 1990. pp. 1869-1887.
16. Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. W Engl J Med 1993; 329:1912-1917.
17. Wilking SV, Belanger A, Kannel WB, D'Agostino RB, Steel K. Determinants of isolated systolic hypertension. J Am Med Assoc 1988; 260:3451-3455.
18. Dahlöf B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-1285.
19. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304:405-412.
20. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP), J Am Med Assoc 1991 ; 265:3255-3264.
21. Joint National Committee on detection, evaluation, and treatment of high blood pressure. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-183.